Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine

Background: Melanoma remains largely resistant to currently available chemotherapy, and new strategies have been proposed to flank standardized therapeutic protocols in an effort to improve efficacy. Such an approach requires good knowledge of the mechanisms involved in the resistance and survival o...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivan Vannini, Massimiliano Bonafe, Anna Tesei, Marco Rosetti, Francesco Fabbri, Gianluca Storci, Paola Ulivi, Giovanni Brigliadori, Dino Amadori, Wainer Zoli
Format: Article
Language:English
Published: Wiley 2007-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.1155/2007/540821
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850215168303169536
author Ivan Vannini
Massimiliano Bonafe
Anna Tesei
Marco Rosetti
Francesco Fabbri
Gianluca Storci
Paola Ulivi
Giovanni Brigliadori
Dino Amadori
Wainer Zoli
author_facet Ivan Vannini
Massimiliano Bonafe
Anna Tesei
Marco Rosetti
Francesco Fabbri
Gianluca Storci
Paola Ulivi
Giovanni Brigliadori
Dino Amadori
Wainer Zoli
author_sort Ivan Vannini
collection DOAJ
description Background: Melanoma remains largely resistant to currently available chemotherapy, and new strategies have been proposed to flank standardized therapeutic protocols in an effort to improve efficacy. Such an approach requires good knowledge of the mechanisms involved in the resistance and survival of melanoma cells. In this context, the SLUG gene has recently been characterized as a major regulator of melanocytes and melanoma cell survival. Methods: We tested the hypothesis that an oligonucleotide-based short interfering RNA (siRNA) directed against the SLUG gene increases the susceptibility of melanoma cells to drugs such as cisplatin and fotemustine, which are frequently used to treat this cancer. Results: It was found that SLUG siRNA increased cisplatin-induced cell death and rendered the drug active in vitro at half its plasmatic peak concentration. Such activity was correlated with an upregulation of the pro-apoptotic gene, PUMA. Furthermore, SLUG siRNA increased the capacity of fotemustine to elicit cell death and induced p21WAF1 upregulation, resulting in cell cycle arrest. Interestingly, this pathway did not require functional p53. Conclusion: These findings suggest that SLUG siRNA enhances the efficacy of two of the most widely used drugs to treat melanoma.
format Article
id doaj-art-8465a2f79f734c1aa55890b51a12283a
institution OA Journals
issn 1570-5870
1875-8606
language English
publishDate 2007-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-8465a2f79f734c1aa55890b51a12283a2025-08-20T02:08:42ZengWileyCellular Oncology1570-58701875-86062007-01-0129427928710.1155/2007/540821Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and FotemustineIvan Vannini0Massimiliano Bonafe1Anna Tesei2Marco Rosetti3Francesco Fabbri4Gianluca Storci5Paola Ulivi6Giovanni Brigliadori7Dino Amadori8Wainer Zoli9Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, ItalyDepartment of Experimental Pathology, University of Bologna and Center for Applied Biomedical Research, Bologna, ItalyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, ItalyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, ItalyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, ItalyDepartment of Experimental Pathology, University of Bologna and Center for Applied Biomedical Research, Bologna, ItalyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, ItalyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, ItalyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, ItalyDepartment of Medical Oncology, Morgagni-Pierantoni Hospital, Forlì, ItalyBackground: Melanoma remains largely resistant to currently available chemotherapy, and new strategies have been proposed to flank standardized therapeutic protocols in an effort to improve efficacy. Such an approach requires good knowledge of the mechanisms involved in the resistance and survival of melanoma cells. In this context, the SLUG gene has recently been characterized as a major regulator of melanocytes and melanoma cell survival. Methods: We tested the hypothesis that an oligonucleotide-based short interfering RNA (siRNA) directed against the SLUG gene increases the susceptibility of melanoma cells to drugs such as cisplatin and fotemustine, which are frequently used to treat this cancer. Results: It was found that SLUG siRNA increased cisplatin-induced cell death and rendered the drug active in vitro at half its plasmatic peak concentration. Such activity was correlated with an upregulation of the pro-apoptotic gene, PUMA. Furthermore, SLUG siRNA increased the capacity of fotemustine to elicit cell death and induced p21WAF1 upregulation, resulting in cell cycle arrest. Interestingly, this pathway did not require functional p53. Conclusion: These findings suggest that SLUG siRNA enhances the efficacy of two of the most widely used drugs to treat melanoma.http://dx.doi.org/10.1155/2007/540821
spellingShingle Ivan Vannini
Massimiliano Bonafe
Anna Tesei
Marco Rosetti
Francesco Fabbri
Gianluca Storci
Paola Ulivi
Giovanni Brigliadori
Dino Amadori
Wainer Zoli
Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine
Cellular Oncology
title Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine
title_full Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine
title_fullStr Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine
title_full_unstemmed Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine
title_short Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine
title_sort short interfering rna directed against the slug gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine
url http://dx.doi.org/10.1155/2007/540821
work_keys_str_mv AT ivanvannini shortinterferingrnadirectedagainstthesluggeneincreasescelldeathinductioninhumanmelanomacelllinesexposedtocisplatinandfotemustine
AT massimilianobonafe shortinterferingrnadirectedagainstthesluggeneincreasescelldeathinductioninhumanmelanomacelllinesexposedtocisplatinandfotemustine
AT annatesei shortinterferingrnadirectedagainstthesluggeneincreasescelldeathinductioninhumanmelanomacelllinesexposedtocisplatinandfotemustine
AT marcorosetti shortinterferingrnadirectedagainstthesluggeneincreasescelldeathinductioninhumanmelanomacelllinesexposedtocisplatinandfotemustine
AT francescofabbri shortinterferingrnadirectedagainstthesluggeneincreasescelldeathinductioninhumanmelanomacelllinesexposedtocisplatinandfotemustine
AT gianlucastorci shortinterferingrnadirectedagainstthesluggeneincreasescelldeathinductioninhumanmelanomacelllinesexposedtocisplatinandfotemustine
AT paolaulivi shortinterferingrnadirectedagainstthesluggeneincreasescelldeathinductioninhumanmelanomacelllinesexposedtocisplatinandfotemustine
AT giovannibrigliadori shortinterferingrnadirectedagainstthesluggeneincreasescelldeathinductioninhumanmelanomacelllinesexposedtocisplatinandfotemustine
AT dinoamadori shortinterferingrnadirectedagainstthesluggeneincreasescelldeathinductioninhumanmelanomacelllinesexposedtocisplatinandfotemustine
AT wainerzoli shortinterferingrnadirectedagainstthesluggeneincreasescelldeathinductioninhumanmelanomacelllinesexposedtocisplatinandfotemustine